← Leaderboards
Shawn J. Skerrett
University Of Washington
$5,911,130
Attributed
$9,495,741
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,495,741 · 9
By mechanism
R01$7,184,230 · 3
R21$1,473,098 · 3
U54$748,029 · 2
R29$90,384 · 1
Top collaborators
- Timothy Eoin West9 shared
- Patrick S. Stayton7 shared
- Daniel M. Ratner5 shared
- Kathie Anne Walters2 shared
- Courtney Crane1 shared
Most similar at University Of Washington
Same institution · by research overlap
- Grace C John-Stewart$42,921,726
- Jairam Rao Lingappa$17,018,282
- Kristina M Adams Waldorf$20,913,441
- Andrew Atwell Oberst$17,614,781
- Joshua Woodward$10,445,693
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionLungAlveolar MacrophagesPneumoniaPathogenExhibitsIn VivoMacrophageMorbidity - Disease RateLegionellosisNovel StrategiesResponseProductionHost DefenseAerosolizedLung InfectionsInflammatoryFrancisellaFrancisella TularensisCytokineCellsTularemiaImmune ResponseBacteria
Grant awards (25)
Combination host-directed and antibacterial therapy for pulmonary intracellular infections$760,910
R01 · FY2025 · AI
Combination host-directed and antibacterial therapy for pulmonary intracellular infections$738,160
R01 · FY2024 · AI
Engineered Antimicrobial Platform to Target Pulmonary Intracellular Infections$633,062
R01 · FY2022 · AI
Global Gene Expression Responses of Francisella tularensis to intracellular Infection of Human Alveolar Macrophages$223,613
R21 · FY2022 · AI · contact PI
Engineered Antimicrobial Platform to Target Pulmonary Intracellular Infections$583,781
R01 · FY2021 · AI
Global Gene Expression Responses of Francisella tularensis to intracellular Infection of Human Alveolar Macrophages$288,407
R21 · FY2021 · AI · contact PI
Genetically engineered macrophages to treat pulmonary infections$216,942
R21 · FY2021 · AI
Engineered Antimicrobial Platform to Target Pulmonary Intracellular Infections$512,525
R01 · FY2020 · AI
Genetically engineered macrophages to treat pulmonary infections$276,097
R21 · FY2020 · AI
Engineered Antimicrobial Platform to Target Pulmonary Intracellular Infections$493,087
R01 · FY2019 · AI
Human Alveolar Macrophage Interactions with Francisella tularensis$207,425
R21 · FY2019 · AI · contact PI
Engineered Antimicrobial Platform to Target Pulmonary Intracellular Infections$493,126
R01 · FY2018 · AI
Human Alveolar Macrophage Interactions with Francisella tularensis$260,614
R21 · FY2018 · AI · contact PI
Pulmonary Defenses Against Intracellular Infection$386,250
R01 · FY2016 · AI · contact PI
Pulmonary Defenses Against Intracellular Infection$386,250
R01 · FY2015 · AI · contact PI
Pulmonary Defenses Against Intracellular Infection$386,250
R01 · FY2014 · AI · contact PI
Pulmonary Defenses Against Intracellular Infection$363,075
R01 · FY2013 · AI · contact PI
Pulmonary Defenses Against Intracellular Infection$386,146
R01 · FY2012 · AI · contact PI
Pulmonary Infection & Inflammation$394,112
U54 · FY2008 · AI · contact PI
Airway Inflammation$353,917
U54 · FY2008 · AI · contact PI
Host Defense Against Intracellular Infection of the Lung$265,300
R01 · FY2005 · HL
Host Defense Against Intracellular Infection of the Lung$265,300
R01 · FY2004 · HL
Host Defense Against Intracellular Infection of the Lung$265,300
R01 · FY2003 · HL
Host Defense Against Intracellular Infection of the Lung$265,708
R01 · FY2002 · HL
HOST DEFENSE AGAINST INTRACELLULAR INFECTION OF THE LUNG$90,384
R29 · FY2000 · HL